CONTACT GSK 1-877-512-1344

Simplify the delivery of triple therapy for your appropriate patients

TRELEGY delivers an ICS/LABA/LAMA in an easy-to-use ELLIPTA inhaler1

The only once-daily triple therapy for COPD in a single inhaler

According to GOLD 2018, use of multiple inhalers is one factor that may lead to poor inhaler technique.2

TRELEGY does not replace a rescue inhaler. Patients should be provided a short-acting beta2-agonist, such as albuterol, to treat acute symptoms and instructed on how it should be used.

Dosing considerations for TRELEGY:

  • administer as one inhalation, once daily
  • take at the same time every day
  • use only once every 24 hours

Instruct patients to rinse their mouths with water after inhalation to reduce the risk of oropharyngeal candidiasis.


Find a TRELEGY representative in your area and request a visit to learn more


TRELEGY simplifies the delivery of triple therapy for COPD in a once-daily inhalation

3 medications. 1 inhaler. 1 daily inhalation.

Delivered in the easy-to-use ELLIPTA inhaler1:

Breath actuated: No hand-breath coordination is required.
Preloaded: Each inhaler contains 30 doses of an ICS/LABA/LAMA.
Single step dose activated: A dose is ready when the cover is opened fully. The counter automatically keeps track of remaining doses.


Keeping samples on hand may help get patients started on once-daily TRELEGY


Each TRELEGY ELLIPTA is preloaded with 30 doses of an ICS, LABA, and LAMA.
The ELLIPTA contains two 30-blister foil strips:

Strip 1 contains fluticasone furoate (100 mcg per blister)
Strip 2 contains a blend of umeclidinium (62.5 mcg per blister) and vilanterol (25 mcg per blister)

For more information, see the Instructions for Use in the Patient Information Leaflet for TRELEGY.


See how to use the ELLIPTA inhaler.

Stay up-to-date with new information on

trelegy ellipta